GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Poniard Pharmaecuticals, Inc. (PARD) [hlAlert]

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of cancer therapy products. Its lead product candidate is picoplatin, a platinum-based cancer therapy. An intravenous chemotherapeutic agent, picoplatin is
designed to overcome platinum resistance in the treatment of solid tumors. The Company initiated a Phase III SPEAR (Study of Picoplatin Efficacy After Relapse) trial of picoplatin in small cell lung cancer. The Company is also conducting separate Phase I/II studies of picoplatin in the treatment of patients with metastatic colorectal cancer and hormone-refractory prostate cancer. NeoRx Manufacturing Group, Inc. is a wholly owned subsidiary of the Company.
.
( Total: 10 Current Stock Recommendations )
Poniard Pharmaecuticals, Inc.   (10)
Sell 20% Hold 20% Buy 60%
Related companies
DARA BIOSCIENCES   (2)
Buy 100%
CELSION CORP   (6)
Buy 100%
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
10/3/2007  
Buy
  
12/1/2008  
Buy
  
2/9/2009  
Buy
  
10/6/2009  
Buy
  
11/16/2009  
Hold
  
11/16/2009  
Hold
  
11/17/2009  
Sell
  
1/25/2010  
Sell
  
4/27/2010  
Buy
  
6/8/2010  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy